@Companyresearch
Painchek - FDA for a De novo device. clinical study took 14months including the report writing.
Botanix - Topical drug for hyperhidrosis. FDA approved. Took 12 months for phase 3.
Resapp FDA rejected. Device for upset repository tract detection. Took 12 months for phase 3
All 3 companies above also quoted unrealistic expectations to share holders for trial completion.
- Forums
- ASX - By Stock
- Ann: PRE-SUBMISSION MEETING WITH US FDA FOR HEART FAILURE
EIQ
echoiq limited
Add to My Watchlist
2.38%
!
21.5¢

@CompanyresearchPainchek - FDA for a De novo device. clinical...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $138.7M |
Open | High | Low | Value | Volume |
21.5¢ | 22.0¢ | 20.5¢ | $321.5K | 1.516M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 212563 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 400412 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 212563 | 0.215 |
2 | 223000 | 0.210 |
13 | 488968 | 0.205 |
14 | 423058 | 0.200 |
2 | 251538 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 400412 | 5 |
0.225 | 156851 | 4 |
0.230 | 244729 | 7 |
0.235 | 170814 | 3 |
0.240 | 46211 | 2 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
EIQ (ASX) Chart |